European Journal of Internal Medicine
Volume 18, Issue 3 , Pages 230-234, May 2007

CPAP titration: Different methods for similar clinical results

Sección de Neumología y Alergia, Hospital Universitario Puerta del Mar, Avda. Ana de Viya, 21, E-11009 Cádiz, Spain

Received 11 June 2006; received in revised form 28 September 2006; accepted 12 October 2006.

Abstract 

Background

Continuous positive airway pressure (CPAP) is the main treatment for obstructive sleep apnea–hypopnea syndrome (OSAHS). Polysomnography (PSG) is the gold standard for CPAP titration. However, alternative methods have been sought to titrate CPAP at less expense in terms of time and resources. The aim of this study was to analyze CPAP success in controlling OSAHS symptoms and adverse effects by two titration methods.

Methods

This was a retrospective, observational cohort study in which 200 CPAP-naive patients who had been referred to our sleep laboratory and diagnosed with OSAHS were evaluated on two consecutive visits. During the first visit, an initial CPAP pressure was established either by split-night PSG or by using a mathematical formula. On the second visit, 1 month later, symptom persistence and adverse effects of CPAP treatment were assessed.

Results

Patients included were 157 males (78.5%) and 43 females (21.5%) aged 56±10 years. 87 patients (43.5%) were titrated by PSG and 113 (56.5%) using the formula. At the second visit, symptoms had improved significantly for both groups with no significant differences in the presence of adverse effects. The initial pressure had to be readjusted in five patients.

Conclusions

This study suggests that formula titration can control symptoms as effectively as split-night titration. A prompt evaluation of the patient is advisable in order to ensure compliance with treatment and to correct possible adverse effects.

Keywords: Obstructive sleep apnea–hypopnea syndrome, Continuous positive airway pressure titration, Adverse effects, Effectiveness of therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(07)00040-4

doi:10.1016/j.ejim.2006.10.004

European Journal of Internal Medicine
Volume 18, Issue 3 , Pages 230-234, May 2007